Impact
BioMedical SIG #8
Nadina Grosios outlines the regulatory path from academic drug discovery to market, highlighting key studies and concepts that support clinical trial submissions, funding access, and partnership building.
Search for resources
Impact
BioMedical SIG #7
Philippe Tschopp explored how aligning manufacturing design with regulatory and clinical strategy enhances the development of oral solid drug products. He focused on GMP, GLP, and TPP as key components for ensuring quality, safety, and scalability.
Impact
BioMedical SIG #6
Thomas Hanke (Evotec) shares his perspective on how to strategically plan and execute preclinical validation for translational academic research. Drawing on his experience at Evotec—a leading biotechnology company specialising in collaborative drug discovery—Hanke highlights best practices to align early-stage research with potential clinical applications.
Journals and Articles
New Frontiers in oncology: an evolving innovation ecosystem
A new study from the European Patent Office (EPO) explores how innovation ecosystems are shaping the future of oncology, with knowledge transfer playing a crucial role in bridging the gap between research and market-ready solutions. New Frontiers in Oncology: An Evolving Innovation Ecosystem provides a comprehensive analysis of patent trends in cancer-related technologies, revealing both the strengths and challenges facing Europe in this critical field.
Impact
BioMedical SIG #4
Learn about essential IP strategies for healthcare spin-outs, focusing on how tailored approaches for biotech, pharma, and digital health innovations can ensure long-term success. Join experts Sara Holland, Dave Holt, and Elisabeth Downey as they guide you through the key elements of a comprehensive IP strategy, including licences and agreements.
Impact
BioMedical SIG #3
Join Katrina Bradley and BioMedical SIG for a webinar on market access strategies in life sciences. Learn to plan, execute, and optimise early tech deployment.
Impact
BioMedical SIG #2
Second webinar of the series, From research and innovation to development: how to plan and execute translational projects in life sciences. This webinar will focus on the process involved with the release of new medical devices.
Impact
BioMedical SIG #1
First webinar of the series, From research and innovation to development: how to plan and execute translational projects in life sciences, From bench to bedside focuses on the process of creating new medicines. Matthias Versele, Executive Director Drug Discovery from Cistim, Belgium, presents CD3-Cistim’s strategy for the evaluation and execution of drug development projects.